We demonstrate that PTX3 production by tumor cells decreases along the progression from low-grade to high-grade/MIBC, with an oncosuppressive impact on the biological features of BC growth, including tumor cell proliferation, motility, metabolism, stemness, and drug resistance. The gene discussed is PTX3; the disease is breast cancer.